264 related articles for article (PubMed ID: 25252097)
1. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
Lin CC; Lai MS; Shau WY
Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan.
Yang YS; Kornelius E; Chiou JY; Lai YR; Lo SC; Peng CH; Huang CN
J Womens Health (Larchmt); 2017 Dec; 26(12):1278-1284. PubMed ID: 28537451
[TBL] [Abstract][Full Text] [Related]
3. Use of non-steroidal anti-inflammatory drugs and risk of chronic kidney disease in people with Type 2 diabetes mellitus, a nationwide longitudinal cohort study.
Tsai HJ; Hsu YH; Huang YW; Chang YK; Liu JS; Hsu CC
Diabet Med; 2015 Mar; 32(3):382-90. PubMed ID: 25313684
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
5. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.
Hollestein LM; van Herk-Sukel MP; Ruiter R; de Vries E; Mathijssen RH; Wiemer EA; Stijnen T; Coebergh JW; Lemmens VE; Herings RM; Stricker BH; Nijsten T
Int J Cancer; 2014 Jul; 135(1):157-65. PubMed ID: 24285345
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.
Friis S; Poulsen AH; Sørensen HT; Tjønneland A; Overvad K; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
Cancer Causes Control; 2009 Jul; 20(5):731-40. PubMed ID: 19122977
[TBL] [Abstract][Full Text] [Related]
7. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.
Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC
Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
[TBL] [Abstract][Full Text] [Related]
10. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
Mahipal A; Anderson KE; Limburg PJ; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
Peleg II; Maibach HT; Brown SH; Wilcox CM
Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
[TBL] [Abstract][Full Text] [Related]
14. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
McCowan C; Munro AJ; Donnan PT; Steele RJ
Eur J Cancer; 2013 Mar; 49(5):1049-57. PubMed ID: 23182687
[TBL] [Abstract][Full Text] [Related]
15. Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden.
Larsson SC; Giovannucci E; Wolk A
Br J Cancer; 2006 Nov; 95(9):1277-9. PubMed ID: 17060932
[TBL] [Abstract][Full Text] [Related]
16. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
17. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
18. Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sedarat A; Lewis JD
Gastroenterology; 2007 Sep; 133(3):748-54. PubMed ID: 17678926
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.
Stürmer T; Buring JE; Lee IM; Kurth T; Gaziano JM; Glynn RJ
Am J Med; 2006 Jun; 119(6):494-502. PubMed ID: 16750963
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
